![]() | ![]() | ![]() | ||||||||||
![]() | ![]() | |||||||||||
1. Miklossy J, Kuntzer T, Bogousslavsky J, Regli F, Janzer RC. Meningovascular form of neuroborreliosis: Similarities between neuropathological findings in a case of Lyme disease and those occurring in tertiary neurosyphilis. Acta Neuropathol 1990;80:568-572. http://www.springerlink.com/content/x7783gx742217207/fulltext.pdf 4. Miklossy J. Kasas S, Janzer RC, Ardizzoni F, Van der Loos H. Further morphological evidence for a spirochetal etiology of Alzheimer's Disease. NeuroReport 1994; 5:1201-1204. IF : 2.374 13. Mooser V, Helbecque N, Miklossy J, Marcovina SM, Nicod P, Amouyel Ph. Interactions between Apolipoprotein E and Apolipoprotein(a) in patients with Late-Onset Alzheimer disease. Ann Intern Med 2000;132:533-537. 14. Suter OC, Sunthorn T, Kraftsik R, Straubel J, Darekar P, Khalili K, Miklossy J. Cerebral hypoperfusion generates cortical watershed microinfarcts in Alzheimer disease. Stroke 2002;33:1986-1992. 15. Helbecque N, Abderrhamani A, Meylan L, Riederer B, Mooser V, Miklossy J, Delplanque J, Boutin P, Nicod P, Haefliger J, Cottel D, Amouyel P, Froguel P, Waeber G. Islet-Brain 1/ C-Jun N-terminal Kinase Interacting protein-1 (IB1/JIP-1) promoter variant is associated with Alzheimer’s disease. Molecular Psychiatry 2003;8:413-22. 16. Miklossy J. Taddei K, Suva D, Verdile G, Fonte J, Fisher C, Gnjec A, Ghika J, Suard Metha PD, McLean CA, Masters CL, Brooks WS, Martins RN. Two novel presenilin-1 mutations (Y256S and Q222H) are associated with early-onset Alzheimer's disease. Neurobiol Aging 2003;24:655-662. 19. Miklossy J, Taddei K, Suva D, Verdile G, Fonte J, Fisher C, Gnjec A, Ghika J, Suard F, Mehta PD, McLean CA, Masters CL, Brooks WS, Martins RN. Two novel presenilin-1 mutations (Y256S and Q222H) are associated with early-onset Alzheimer's disease. Neurobiol Aging. 2003;24:655-662. 20. Miklossy J, Khalili K, Gern L, Ericson RL, Darekar P, Bolle L, Hurlimann J, Paster BJ. Borrelia burgdorferi persists in the brain in chronic Lyme neuroborreliosis and may be associated with Alzheimer disease. J Alzheimer’s Dis 2004;6:639-649. 21. von Gunten A, Miklossy J, Suva ML, Hof PR, Giannakopoulos P. Environmental reduplicative paramnesia in a case of atypical Alzheimer's disease. Neurology 2004; 251:750-752. 22. Verdile G, Gnjec A, Miklossy J, Fonte J, Veurink G, Bates K, Kakulas B, Mehta PD, Milward EA, Tan N, Lareu R, Lim D, Dharmarajan A, Martins RN. Protein markers for Alzheimer disease in the frontal cortex and cerebellum. Neurology. 2004;63:1385-1392.
24. Miller L.M., Wang AQ, Telivala TP, Randy J, , Smith RJ, Lanzirotti A., Miklossy J. Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with beta-amyloid deposits in Alzheimer's disease. J Struct Biol. 2006;155:30-379. (Science Direct: between the 25 hottest articles, 2006) 26. Arai T, Miklossy J, Klegeris A, Guo JP, McGeer PL. Thrombin and prothrombin are expressed by neurons and glial cells and accumulate in neurofibrillary tangles in Alzheimer disease brain. J Neuropathol Exp Neurol. 2006;65:19-25. 27. Arai T, Akiyama H, J Miklossy, Guo JP, Klegeris A. Thrombin is a brain protease that processes tau. Neuropathology, 2006; 26:A8. 28. Miklossy J, Rosemberg S, McGeer PL. Beta amyloid deposition in the atrophic form of general paresis. In: Alzheimer’s Disease: New advances. Eds: Iqbal K, Winblad B, J Avila. Medimond. Intyernational Proceedings. Proceedings of the 10th International Congress on Alzheimer’s Disease (ICAD) 2006; pp. 429-433. 29. Guo J, Arai T, Miklossy J, and McGeer PL. A-beta and tau form soluble complexes that may promote self aggregation of both into the insoluble forms observed in Alzheimer disease. P.N.A.S. Proc Natl Acad Sci U S A. 2006 Feb 7;103(6):1953-1958. Epub 2006 Jan 30. Press release 31. Hashioka S, Miklossy J, Schwab S, Klegeris A, McGeer PL. Adhesion of exogenous human microglia and THP-1 cells to amyloid plaques of postmortem Alzheimer’s disease brain. J Alzheimer Dis 2008; 14: 345-352 32. Darbinian N, Cui J, Basile A, Del Valle L, Miklossy J, Sawaya BE, Amini S, Khalili K, and Gordon J. Negative regulation of AbPP gene expression by Pur-alpha. J Alzheimer’s Dis 2008; 15: 71-82 33. Gnjec A, D'Costa KJ, Laws SM, Hedley R, Balakrishnan K, Taddei K, Martins G, Paton A, Verdile G, Gandy SE, Broe GA, Brooks WS, Bennett H, Piguet O, Price P, Miklossy J, Hallmayer J, McGeer PL, Martins RN. Association of alleles carried at TNFA -850 and BAT1 -22 with Alzheimer's disease. J Neuroinflammation. 2008; 5:36. 34. Miklossy J. Chronic inflammation and amyloidogenesis in Alzheimer's disease – role of spirochetes. J. Alzheimer’s Dis. 2008;13:381-391 35. Weinberg ED, Miklossy J. Iron withholding: a defense against disease. Alzheimer’s Dis. 2008;13: (in press). http://www.j-alz.com/issues/13/vol13-4.html 36. Miklossy J, Martins RN, Darbinian N, Khalili K, McGeer PL. Type 2 diabetes: Local inflammation and direct effect of bacterial toxic products. Open Pathol J, 2008, 2: 86-95 37. Miklossy J, Kasas S, Zurn A, McCall S, Yu S, McGeer PL. Persisting atypical and cystic forms of Borrelia burgdorferi and local inflammation in Lyme neuroborreliosis. J. Neuroinflammation. 2008, 5:40 38. Miklossy J, Qing H, Radenovic A, Kis A, Vileno B, Làszló F, Miller L, Martins RN, Waeber G, Mooser V, Bosman F, Khalili K, Darbinian-Sarlissian N, McGeer PL. Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes. Neurobiol Aging. 2010;31:1503-1515, PMID: 18950899 | ||||||||||||